Regor Therapeutics
Boston
About Regor Therapeutics
Regor Therapeutics is a clinical-stage company dedicated to the discovery and development of innovative and clinically differentiated medicines by leveraging the proprietary CARD (Computer Accelerated Rational Discovery) Platform, seamlessly integrating structural biology, computational chemistry, therapeutic biology, medicinal chemistry, and clinical development. Regor has assembled a world-class scientific team and demonstrated high efficiency in producing best- and first-in-class molecules.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $140.0M
- Last round: Series Unknown (Dec 2021)
- Website: regor.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/regor-therapeutics-38909 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.